Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2025-03-11 00:00:00 ET · period of report 2025-03-07 · accession 0001819790-25-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-11 | 2025-03-07 | TARS | Goldberg Andrew D. | Dir | M - OptEx | $12.89 | +7,000 | 13.3K | +110% | +$90.2K |
| D | 2025-03-11 | 2025-03-07 | TARS | Goldberg Andrew D. | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-07 | M | A | 7,000 | $12.89 | 13,350 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2025-03-07 | M | D | 7,000 | $0.00 | 0 | D | $12.89 · — to 2032-06-15 | 7,000 Common Stock | (F1) Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2021 annual meeting of stockholders. The option vested in full on the one-year anniversary of the date of grant. |